申请人:Lilly Industries Limited
公开号:US04904686A1
公开(公告)日:1990-02-27
Compounds of the following formula have pharmacutical properties: ##STR1## in which R.sup.1 and R.sup.2 independently are hydrogen, halo, nitro, amino, C.sub.2-5 acylamino, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, C.sub.1-4 alkylsulphonyl, N-substituted heterocyclyl, optionally substituted phenyl, optionally substituted phenylthio, optionally substituted phenylsulphonyl or optionally substituted phenylsulphonamido, or R.sup.1 and R.sup.2 together form a C.sub.3-5 alkylene bridge, R.sup.3 is C.sub.1-4 alkyl or C.sub.2-4 alkenyl, and X is (i) --(CH.sub.2).sub.n N(R.sup.4).sub.2 where each R.sup.4 independently is C.sub.1-4 alkyl, C.sub.2-4 alkenyl or optionally substituted C.sub.6 H.sub.5 CH.sub.2 --, and n is 1, 2 or 3, or (ii) a 5- to 8-membered alicyclic group containing one or two nitrogen atoms and directly attached to the amido nitrogen or attached by a C.sub.1-3 alkylene chain; and salts thereof.
以下公式化合物具有药理学性质:##STR1## 其中R.sup.1和R.sup.2独立地是氢、卤素、硝基、氨基、C.sub.2-5酰胺基、C.sub.1-4烷基、C.sub.1-4烷氧基、C.sub.1-4烷基硫基、C.sub.1-4烷基磺酰基、N-取代杂环烷基、可选择取代苯基、可选择取代苯硫基、可选择取代苯磺酰基或可选择取代苯磺酰胺基,或者R.sup.1和R.sup.2一起形成C.sub.3-5烷基桥,R.sup.3是C.sub.1-4烷基或C.sub.2-4烯基,X是(i) --(CH.sub.2).sub.nN(R.sup.4).sub.2,其中每个R.sup.4独立地是C.sub.1-4烷基、C.sub.2-4烯基或可选择取代的C.sub.6 H.sub.5 CH.sub.2--,n为1、2或3,或(ii) 一个含有一个或两个氮原子的5至8元环脂肪族基团,直接连接到酰胺氮原子或通过C.sub.1-3烷基链连接;及其盐。